secwatch.observer — SEC 8-K summary
======================================

Issuer:     KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
CIK:        0001877184
Form:       8-K
Filed at:   2025-07-15T23:59:59+00:00
Accession:  0000950170-25-095869
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kestra Medical Q4 rev $17.2M (+71%), FY rev $59.8M (+115%); guides FY26 $85M
----------------------------------------------------------------------------

- Q4 revenue $17.2M (+71% YoY); FY25 revenue $59.8M (+115% YoY).
- Q4 gross margin 44.3% vs 13.9% prior year; FY gross margin 40.5% vs 1.3%.
- Q4 prescriptions: 3,903 (+43% YoY); FY prescriptions: 13,193 (+72% YoY).
- FY26 revenue guidance initiated at $85M, representing 42% growth over FY25.
- GAAP net loss $51.1M in Q4; adjusted EBITDA loss $20.3M; cash $237.6M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1877184/000095017025095869/0000950170-25-095869-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1877184/000095017025095869/ck0001877184-20250715.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-095869

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer